DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 64 filers reported holding DESIGN THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,691,689 | -63.1% | 716,818 | -1.6% | 0.00% | -66.7% |
| Q2 2023 | $4,587,798 | +10.4% | 728,221 | +1.2% | 0.00% | 0.0% |
| Q1 2023 | $4,154,036 | -48.3% | 719,937 | -8.0% | 0.00% | -50.0% |
| Q4 2022 | $8,030,594 | -41.4% | 782,709 | -4.5% | 0.01% | -45.5% |
| Q3 2022 | $13,710,000 | +29.9% | 819,986 | +8.8% | 0.01% | +37.5% |
| Q2 2022 | $10,552,000 | +20.1% | 753,693 | +38.6% | 0.01% | +33.3% |
| Q1 2022 | $8,784,000 | -21.5% | 543,912 | +4.1% | 0.01% | -14.3% |
| Q4 2021 | $11,185,000 | +245.3% | 522,454 | +136.9% | 0.01% | +250.0% |
| Q3 2021 | $3,239,000 | -23.0% | 220,510 | +4.3% | 0.00% | -33.3% |
| Q2 2021 | $4,207,000 | +31.0% | 211,502 | +96.9% | 0.00% | +50.0% |
| Q1 2021 | $3,212,000 | – | 107,408 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 6,526,476 | $15,402,483 | 7.89% |
| Logos Global Management LP | 5,032,501 | $11,876,702 | 1.58% |
| Prosight Management, LP | 1,203,745 | $2,840,838 | 0.90% |
| TANG CAPITAL MANAGEMENT LLC | 1,350,000 | $3,186,000 | 0.45% |
| Soleus Capital Management, L.P. | 1,025,000 | $2,419,000 | 0.22% |
| RTW INVESTMENTS, LP | 2,512,986 | $5,930,647 | 0.12% |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 180,000 | $425,000 | 0.09% |
| Corton Capital Inc. | 27,134 | $64,036 | 0.03% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 100,722 | $237,704 | 0.03% |
| Rock Springs Capital Management LP | 460,391 | $1,086,523 | 0.03% |